Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (141-150 of 666) with videos related to

Pageof 67
Sort By:
Journal of Analytical Toxicology|October 24, 2000
A fatality due to accidental PineSol ingestionC J Cording, G M Vallaro, R Deluca, et al.
Cancer Research|September 1, 1990
Evaluation of cysteine adduct formation in rat hemoglobin by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and related compoundsS G Carmella, S S Kagan, T E Spratt, et al.
Biochemistry|April 11, 2012
Structure and dynamics of calmodulin (CaM) bound to nitric oxide synthase peptides: effects of a phosphomimetic CaM mutationMichael Piazza, Kathryn Futrega, Donald E Spratt, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Translational and clinical implications of the genetic landscape of prostate cancerDaniel E Spratt, Zachary S Zumsteg, Felix Y Feng, et al.
The Lancet. Oncology|June 15, 2016
Vessel-sparing radiation and functional anatomy-based preservation for erectile function after prostate radiotherapyJae Y Lee, Daniel E Spratt, Adam L Liss, et al.
NPJ Breast Cancer|October 16, 2020
ARe we there yet? Understanding androgen receptor signaling in breast cancerAnna R Michmerhuizen, Daniel E Spratt, Lori J Pierce, et al.
Chemical Research in Toxicology|July 1, 1990
Solvolysis of model compounds for alpha-hydroxylation of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: evidence for a cyclic oxonium ion intermediate in the alkylation of nucleophilesT E Spratt, L A Peterson, W L Confer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 2, 2008
Glucuronidation of tobacco-specific nitrosamines by UGT2B10Gang Chen, Ryan W Dellinger, Dongxiao Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2019
Reply to J.R. Rider et alPayal D Soni, Holly E Hartman, Matthew J Schipper, et al.
American Journal of Clinical Oncology|October 10, 2023
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients: Incidence and Success Rate of Peer-To-Peer Authorization in Allowing Patients to Remain Trial-EligibleShearwood McClelland, Melissa Brately, Raed J Zuhour, et al.
Pageof 67

Showing results (141-150 of 666) with videos related to

Sort By:
Pageof 67
Journal of Analytical Toxicology|October 24, 2000
A fatality due to accidental PineSol ingestionC J Cording, G M Vallaro, R Deluca, et al.
Cancer Research|September 1, 1990
Evaluation of cysteine adduct formation in rat hemoglobin by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and related compoundsS G Carmella, S S Kagan, T E Spratt, et al.
Biochemistry|April 11, 2012
Structure and dynamics of calmodulin (CaM) bound to nitric oxide synthase peptides: effects of a phosphomimetic CaM mutationMichael Piazza, Kathryn Futrega, Donald E Spratt, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Translational and clinical implications of the genetic landscape of prostate cancerDaniel E Spratt, Zachary S Zumsteg, Felix Y Feng, et al.
The Lancet. Oncology|June 15, 2016
Vessel-sparing radiation and functional anatomy-based preservation for erectile function after prostate radiotherapyJae Y Lee, Daniel E Spratt, Adam L Liss, et al.
NPJ Breast Cancer|October 16, 2020
ARe we there yet? Understanding androgen receptor signaling in breast cancerAnna R Michmerhuizen, Daniel E Spratt, Lori J Pierce, et al.
Chemical Research in Toxicology|July 1, 1990
Solvolysis of model compounds for alpha-hydroxylation of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: evidence for a cyclic oxonium ion intermediate in the alkylation of nucleophilesT E Spratt, L A Peterson, W L Confer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 2, 2008
Glucuronidation of tobacco-specific nitrosamines by UGT2B10Gang Chen, Ryan W Dellinger, Dongxiao Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2019
Reply to J.R. Rider et alPayal D Soni, Holly E Hartman, Matthew J Schipper, et al.
American Journal of Clinical Oncology|October 10, 2023
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients: Incidence and Success Rate of Peer-To-Peer Authorization in Allowing Patients to Remain Trial-EligibleShearwood McClelland, Melissa Brately, Raed J Zuhour, et al.
Pageof 67